Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) Stock Price

SNOAStock

$1.35−73.67%52W

Market Cap$6.46M

P/E—

PEG Ratio1.08

Div yield—

Beta1.32

SNOA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-63.56%

Price vs S&P 500 (4W)14.49%

PEG Ratio1.08

VGM Score65.39

Book Value / Share (Quarterly)$1.72

P/TBV (Annual)0.29x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.75%

Cash Flow / Share (Quarterly)$-2.29

Price vs S&P 500 (YTD)-75.15%

Gross Margin (TTM)37.97%

Net Profit Margin (TTM)-16.26%

EPS (TTM)$-1.89

10-Day Avg Trading Volume0.12M

EPS Excl Extra (TTM)$-1.89

Revenue Growth (5Y)0.95%

EPS (Annual)$-1.89

ROI (Annual)-95.72%

Gross Margin (Annual)37.97%

Net Profit Margin (5Y Avg)-31.51%

Cash / Share (Quarterly)$1.33

Revenue Growth QoQ (YoY)48.14%

ROA (Last FY)-22.74%

Revenue Growth TTM (YoY)36.68%

EBITD / Share (TTM)$-1.38

ROE (5Y Avg)-76.56%

Operating Margin (TTM)-12.60%

Cash Flow / Share (Annual)$-2.29

P/B Ratio2.08x

P/B Ratio (Quarterly)1.19x

Net Income / Employee (Annual)$-18,900

EV / Revenue (TTM)0.22x

Net Interest Coverage (TTM)-1.36x

ROA (TTM)-22.67%

EPS Incl Extra (Annual)$-1.89

Current Ratio (Annual)2.50x

Quick Ratio (Quarterly)1.04x

3-Month Avg Trading Volume0.23M

52-Week Price Return-73.67%

Revenue / Employee (TTM)$116,200

Tangible BV / Share (Quarterly)$1.10

P/S Ratio (Annual)0.33x

Asset Turnover (Annual)1.40x

52-Week High$5.18

Operating Margin (5Y Avg)-30.16%

EPS Excl Extra (Annual)$-1.89

CapEx CAGR (5Y)1.30%

Tangible BV CAGR (5Y)-12.24%

26-Week Price Return-52.31%

Quick Ratio (Annual)1.64x

13-Week Price Return26.42%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)2.50x

Enterprise Value$4.26M

Revenue / Share Growth (5Y)4.48%

Asset Turnover (TTM)1.39x

Book Value / Share Growth (5Y)-7.71%

Revenue / Employee (Annual)$116,200

Inventory Turnover (Annual)3.69x

Pretax Margin (Annual)-17.51%

Cash / Share (Annual)$1.33

3-Month Return Std Dev61.72%

Gross Margin (5Y Avg)36.46%

Net Income / Employee (TTM)$-18,900

ROE (Last FY)-102.58%

Net Interest Coverage (Annual)-327.00x

EPS Basic Excl Extra (Annual)$-1.89

P/FCF (TTM)6.16x

Receivables Turnover (TTM)8.21x

Total Debt / Equity (Quarterly)0.07x

EPS Incl Extra (TTM)$-1.89

Receivables Turnover (Annual)8.21x

ROI (TTM)-85.89%

P/S Ratio (TTM)0.33x

Pretax Margin (5Y Avg)-31.86%

Revenue / Share (Annual)$11.60

Tangible BV / Share (Annual)$1.62

Price vs S&P 500 (52W)-91.98%

Year-to-Date Return-63.19%

5-Day Price Return3.08%

EPS Normalized (Annual)$-1.89

ROA (5Y Avg)-27.90%

Net Profit Margin (Annual)-16.26%

Month-to-Date Return21.82%

Cash Flow / Share (TTM)$-1.37

EBITD / Share (Annual)$-1.38

Operating Margin (Annual)-12.60%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-72.00%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.89

P/TBV (Quarterly)0.41x

P/B Ratio (Annual)1.19x

Inventory Turnover (TTM)3.69x

Pretax Margin (TTM)-17.51%

Book Value / Share (Annual)$1.72

Price vs S&P 500 (13W)23.62%

Beta1.32x

P/FCF (Annual)7.24x

Revenue / Share (TTM)$11.26

ROE (TTM)-88.38%

52-Week Low$0.85

vGradeA

gGradeB

mGradeC

vgmGradeB

SNOA Earnings Surprise History

Q2 25-0.76est. -0.51

Q3 25-0.32est. -0.31

Q4 25-0.48est. -0.29

SNOA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.29

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
SNOASonoma Pharmaceuticals, Inc. Common Stock	A	B	C	$1.35
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Sonoma Pharmaceuticals, Inc. Common Stock

Sonoma Pharmaceuticals is a specialty pharmaceutical company focused on medical dermatology, developing therapies for chronic skin conditions including acne, atopic dermatitis, and scarring. Its product portfolio includes Celacyn, Mondoxyne, Alevicyn, Microcyn, and Ceramax Skin Barrier Cream, treating conditions such as scars, itchy skin, and minor irritations. The company generates revenue from product sales in the United States, Latin America, Europe, and Asia.